Mirum Pharmaceuticals MIRM
NASDAQ MIRM
$100.90 +0.27 (+0.27%)
As of: Sep 4, 2026 · 3:59 PM EDT

Mirum Pharmaceuticals (MIRM) Operating Margin (QoQ) (2021 - 2026)

Analysis

Mirum Pharmaceuticals (MIRM) Operating Margin (QoQ) (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Mirum Pharmaceuticals 6.40 Bn 5.96 Bn 145.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 46,964.00
Mar 31, 2026 -49,071.00
Dec 31, 2025 -502.00
Sep 30, 2025 586.00
Jun 30, 2025 970.00
Mar 31, 2025 1,076.00
Dec 31, 2024 -1,033.00
Sep 30, 2024 1,708.00
Jun 30, 2024 712.00
Mar 31, 2024 861.00
Dec 31, 2023 585.00
Sep 30, 2023 1,204.00
Jun 30, 2023 2,118.00
Mar 31, 2023 3,650.00
Dec 31, 2022 5,268.00
Sep 30, 2022 474.00
Jun 30, 2022 7,410.00
Mar 31, 2022 119,843.00
Dec 31, 2021 -59,588.00
Sep 30, 2021 -51,647.00